Compared to individuals in the study who had low depression...
Category:
Health
Latest
Study suggests strong social connections help to improve health
The study also found that having strong bonds with both close...
India continuously striving to provide high-quality, cost-effective healthcare to everyone: Mandaviya
Union Health Minister Mansukh Mandaviya India's experience has...
Malaysia detects coronavirus strain that’s ten times more infectious
The strain could mean that existing studies on vaccines may be incomplete or ineffective against the mutation, said Director-General of Health Noor Hisham Abdullah.
WHO says people in 20s, 30s, 40s increasingly driving pandemic
“Maybe that’s a good thing to have a virus that is more infectious but less deadly,” Tambyah told Reuters.
Tambyah said most viruses tend to become less virulent as they mutate.
“It is in the virus’ interest to infect more people but not to kill them because a virus depends on the host for food and for shelter,” he said.
India’s coronavirus death toll surpasses 50,000,total number of tests cross the 3 crore mark
Implementation of testing aggressively, tracking comprehensively and treating efficiently through a plethora of measures have contributed to the existing high level of recoveries as well, it said. The total number of recoveries in the country rose to 18,62,258 on Sunday, according to official data.
Improved and effective clinical treatment in hospitals, supervised home isolation, use of non-invasive oxygen support, and improved services of the ambulances for ferrying patients for prompt and timely treatment have been the focus of the Centre and state and UT governments, the ministry said.
Blow to WHO? EU clinches first Covid-19 vaccine deal with AstraZeneca
The European Commission, which is negotiating on behalf of all 27 EU member states, said the deal included an option to purchase 100 million additional doses from the British drugmaker should its vaccine prove safe and effective.
The EU’s bilateral deal mirrors moves by the United States and other wealthy states, some of which are critical of the WHO’s initiative, and further reduces the potentially available stock in the race to secure effective Covid-19 vaccines.
The EU move could complicate efforts led by the WHO and GAVI, a global alliance for vaccines, to buy shots on behalf of rich and developing countries with a separate scheme.
The Commission has urged EU states to shun the WHO-led initiative because it sees it as too expensive and slow, EU officials told Reuters in July
China grants country’s first COVID-19 vaccine patent to CanSino: state media
Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries.
National Digital Health Mission rolled out on pilot mode in Chandigarh, 5 different UTs
Welcoming the historic announcement by the prime minister, Union Health Minister Harsh Vardhan mentioned, “Based on the initial learnings in the UTs, we will gradually work in partnership with the states to launch the NDHM. I seek the whole-hearted support, inputs and cooperation of doctors, healthcare facilities, citizens and state governments to adopt this game-changing scheme.”
The NDHM is a holistic, voluntary healthcare programme that may scale back the prevailing hole between numerous stakeholders reminiscent of docs, hospitals and different healthcare suppliers, pharmacies, insurance coverage firms, and residents by bringing them collectively and connecting them in an built-in digital well being infrastructure, the NHA assertion mentioned.
“Covid warriors will be first to get vaccinated, once we get it”: MoS Health
Phase 1 and 2 human clinical trials of two of the vaccine candidates, developed indigenously by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR), and Zydus Cadila Ltd, are currently underway.
The Serum Institute of India has been permitted to conduct Phase 2 and 3 human clinical trials of the third vaccine candidate developed by Oxford University. The Pune-based institute has partnered with AstraZeneca for manufacturing the vaccine.
COVID-19:Over 63,000 fresh cases, tally climbs to 25,89,682,death toll nears50k
The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
ndia has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new cases of the infection.
The case fatality rate has declined to 1.93 per cent.
There are 6,77,444 active cases of coronavirus infection in the country presently which comprise 26.16 per cent of the total caseload in the country.
USFDA clears simple saliva test for faster detection of COVID-19
With the FDA’s emergency use authorisation, the testing method is immediately available to other diagnostic laboratories that want to start using the new test, which can be scaled up quickly for use across the nation and, perhaps, beyond in the coming weeks, researchers said
”This is a huge step forward to make testing more accessible,” said Chantal Vogels, a Yale postdoctoral fellow, who led the laboratory development and validation along with Doug Brackney, an adjunct assistant clinical professor.
Demand for tech-enabled healthcare solutions rising due to COVID-19 impact: Report
“Consumers are increasingly preferring to have their healthcare needs met remotely or from the comfort and safety of their homes. They expect their healthcare service providers to prioritise adherence to safety protocols,” the report noted.